Skip to main content

Table 3 Statistical analysis of pretreatment hemoglobin parameters with tumor pathological variables a

From: Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria

 

tHb

oxyHb

deoxyHb

Tumor type

NS

MC/10 hpf

Triple-negative

HER2

ER

tHb

 

0.841

0.637

0.166

0.430

0.206

0.108

0.144

0.312

P < 0.001

P < 0.001

P = 0.333

P = 0.009

P = 0.229

P = 0.532

P = 0.404

P = 0.064

oxyHb

  

0.302

0.066

0.234

0.005

0.115

0.108

0.330

P = 0.074

P = 0.703

P = 0.170

P = 0.979

P = 0.505

P = 0.532

P = 0.049

deoxyHb

   

0.050

0.356

0.292

0.093

0.086

0.275

P = 0.771

P = 0.033

P = 0.084

P = 0.589

P = 0.618

P = 0.105

  1. adeoxyHb, Deoxygenated hemoglobin; ER, Estrogen receptor; HER2, Human epidermal growth factor receptor 2; hpf, High-power field; MC, Mitotic count; NS, Nottingham score; oxyHb, Oxygenated hemoglobin; tHb, Total hemoglobin.